NCT03412604View on ClinicalTrials.gov

Effect of Modulating Gamma Oscillations Using tACS

NACompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

August 2, 2018

Primary Completion Date

May 7, 2019

Study Completion Date

September 15, 2019

Conditions
Alzheimer Disease
Interventions
DEVICE

Transcranial Alternating Current Stimulation (tACS)

tACS will be applied at a frequency of 40Hz and targeting the area of maximal tracer uptake on amyloid PET imaging using an individualized multielectrode design to maximize the induced electrical current to the target region.

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
collaborator

Defense Advanced Research Projects Agency

FED

lead

Massachusetts General Hospital

OTHER

NCT03412604 - Effect of Modulating Gamma Oscillations Using tACS | Biotech Hunter | Biotech Hunter